Drug Shortage Report for PMS-ZOLMITRIPTAN ODT
Report ID | 149263 |
Drug Identification Number | 02324768 |
Brand name | PMS-ZOLMITRIPTAN ODT |
Common or Proper name | ZOLMITRIPTAN ODT |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-14 |
Estimated end date | Unknown |
Actual end date | 2022-06-27 |
Shortage status | Resolved |
Updated date | 2022-07-25 |
Company comments | Please see Discontinuation report # 165469 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-07-25 | French | Compare |
v4 | 2022-07-25 | French | Compare |
v3 | 2022-07-25 | English | Compare |
v2 | 2021-11-15 | French | Compare |
v1 | 2021-11-15 | English | Compare |
Showing 1 to 5 of 5